Fairness to Kids with Cancer Act of 2025

Legislative bill overview

HR 6054, the Fairness to Kids with Cancer Act of 2025, addresses healthcare access and treatment equity for pediatric cancer patients. The bill was introduced in November 2025 and referred to the House Committee on Energy and Commerce for consideration. Specific provisions have not yet been publicly detailed in legislative summaries.

Why is this important

Pediatric cancer treatment involves complex medical, financial, and insurance barriers that can affect survival outcomes and family financial stability. Legislation targeting fairness in this context could impact insurance coverage policies, drug access, clinical trial participation, or treatment cost protections for affected children and families.

Potential points of contention

• Insurance coverage standards: Disagreement may arise over whether federal mandates should require specific coverage levels or treatments for pediatric cancer care
• Pharmaceutical pricing: Balancing patient access to cancer drugs against pharmaceutical company profitability and R&D incentives
• Implementation costs: Determining who bears financial responsibility—insurers, government programs, hospitals, or combinations thereof—and overall budgetary impact